Review of the clinical approach to the treatment of disruptive mood dysregulation disorder

Abstract

Though a decade of research led to the creation of disruptive mood dysregulation disorder (DMDD), it was not until the 2013 publication of the DSM-5 that DMDD became an official diagnosis. The conception of DMDD was largely due to increasing rates of paediatric bipolar disorder (PBD) diagnoses, which significantly impacted treatment for these youth. The core symptoms of DMDD include persistent irritability and recurrent outbursts; the absence of a previous diagnostic category for youth experiencing these symptoms may have led to the over diagnosis of PBD. Due to the chronicity of symptoms, these youth are impaired in multiple areas of functioning. This article will present background information about DMDD, discuss clinical assessment strategies including scales for measuring irritability and aggression, and review pharmacologic and psychosocial treatments for youth with DMDD and clinical phenotypes similar to DMDD.

Keywords:

• Disruptive mood dysregulation disorder
• mood disorder
• child and adolescent mental health
• psychosocial treatment
• pharmacologic treatment
• assessment

Disclosure statement

The other authors report no conflict of interest.

Additional information

Funding

Dr. Miller receives grant funding from PCORI and Once Upon a Time Foundation.